LON:VEC Vectura Group (VEC) Share Forecast, Price & News GBX 164.80 0.00 (0.00%) (As of 10/18/2021) Add Compare Share Share Today's Range 164.63▼ 16550-Day Range 164.80▼ 164.8052-Week Range 100▼ 176Volume203,761 shsAverage Volume3.37 million shsMarket Capitalization£1.01 billionP/E Ratio8.20Dividend Yield23.06%Price TargetN/A ProfileProfileChartCompetitorsInsider TradesHeadlinesOptions ChainProfileChartCompetitorsInsider TradesHeadlinesOptions Chain About Vectura Group (LON:VEC) StockVectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide. The company's in-market products include Seebri, Breezhaler and Neohaler, a DPI device and bronchodilator; AirFluSal Forspiro for the treatment of asthma and chronic obstructive pulmonary disease (COPD); Breelib for the treatment of pulmonary arterial hypertension; Relvar Ellipta/Breo Ellipta that is used in treating asthma and COPD; and Incruse Ellipta, Anoro Ellipta, and Trelegy Ellipta for the treatment of COPD. It is also developing VR315 (US) for the treatment of asthma and COPD.In addition, the company offers dry powder inhalers, pressurized metered dose inhalers, and nebulized devices. Vectura Group plc was founded in 1997 and is headquartered in Chippenham, the United Kingdom.Read More Receive VEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vectura Group and its competitors with MarketBeat's FREE daily newsletter. Email Address VEC Stock News HeadlinesMay 17, 2023 | marketwatch.comIpratropium Bromide Market Forthcoming Trends and Share Analysis by 2031May 8, 2023 | marketwatch.comLatest "Ipratropium Bromide Market" Size Forecast 2023-2031: New Challenges, Drivers, and RestraintsMay 27, 2023 | Behind the Markets (Ad)The 4th Military Revolution is Happening. There have been 3 military revolutions in the past 100 years. The first was when the tank was invented in 1915. The second was the nuclear bomb in 1945. The third was the "smart bomb" in 1991. Amid the turmoil, there will be many losers. Click here to see how to win instead >>>May 3, 2023 | marketwatch.com2023-2030 Targeted Drug Delivery System Market Size (Growth and Outlook) includes Latest Development | with [124 Pages]April 30, 2023 | marketwatch.comNebulizers Market is poised to cross USD 1.9 billion by 2032April 25, 2023 | marketwatch.comIpratropium Bromide Market Manufacturing Cost Structure By 2030April 22, 2023 | marketwatch.com2023-2030 Potassium Gluconate Market Size with [96 Pages] includes Market Restraints | New Report by Absolute ReportsApril 3, 2023 | finance.yahoo.comAerami Therapeutics to Host Virtual Investor Day with Leading Experts in Pulmonary Hypertension as AER-901 (Inhaled Imatinib) Advances Toward Phase 2May 27, 2023 | Behind the Markets (Ad)"Chilling War Games Show US Forces Crushed" – FOX NEWS=== BREAKING === "Chilling War Games Show US Forces Crushed" - FOX NEWS After losing to China in repeated war games, U.S. military to spend billions on new "living missile" for armed forces. Investors stand to reap 35,960% on shares of small defense contractor that makes powerful new weapon. Get the name of the stock here >>>March 28, 2023 | marketwatch.comPolymers Drug Delivery Market Share and Forecast till 2031March 28, 2023 | marketwatch.comIpratropium Bromide Market Share and Forecast till 2028March 28, 2023 | marketwatch.comAsthma and COPD Drugs Market Outlook and Forecast till 2031March 27, 2023 | marketwatch.comOral Drug Delivery Market Growth and Forecast till 2031March 24, 2023 | marketwatch.comMedical Suction Catheters Market Size, Share, Growth | Global Report, 2031March 22, 2023 | marketwatch.comBronchodilators Market Trends Business Opportunities, Segments and Industry Forecast By 2031March 17, 2023 | marketwatch.comCOPD Drugs Market Growth and Forecast till 2028March 15, 2023 | marketwatch.comCOPD Drugs Market Size 2023 Research Report by Manufacturing Process Analysis and Forecast till 2027March 14, 2023 | marketwatch.comTyrosine Protein Kinase JAK1 Market Size 2023 Research Report by Consumption Analysis and Forecast till 2027March 10, 2023 | marketwatch.comDry Powder Inhaler Market Challenges Analysis, Sales Volume, Share and Forecast ResearchFebruary 28, 2023 | marketwatch.comDry Powder Inhaler Market to Grow Significantly by Leading Players 2023 to 2028February 28, 2023 | marketwatch.comGlobal Pulmonary Hypertension Drug Market Insights, Emerging Trends and Latest Opportunities 2023 – 2030 By VMReportsFebruary 22, 2023 | uk.finance.yahoo.comThe Global Nebulizer Market size is expected to reach $1.4 billion by 2028, rising at a market growth of 5.6% CAGR during the forecast periodFebruary 22, 2023 | marketwatch.comAsthma Drugs Market is Booming in Near Future 2023-2028 with Top Countries DataFebruary 19, 2023 | marketwatch.comAnalyzing The Intelligent Asthma Monitoring Devices Market 2023: Proven Strategies for Significant and Trends by 2028February 17, 2023 | marketwatch.comTargeted Drug Delivery System Market 2023 Size Industry, Current Trends, Demand and Size Share Estimation by 2028 with Top PlayersFebruary 17, 2023 | marketwatch.comCOPD Drugs Market Outlook 2023 and Forecast to 2028 with Top Countries DataFebruary 14, 2023 | marketwatch.comPolymers Drug Delivery Market Outlook 2023 and Forecast to 2028 with Top Countries DataSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive VEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vectura Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON Industry Drug Manufacturers - Major Sub-IndustryN/A SectorMedical Current SymbolLON:VEC CUSIPN/A CIKN/A Webwww.vectura.com Phone+44-1249-667700FaxN/AEmployees9,200Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio8.20 Forward P/E Ratio0.18 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.77 Current Ratio3.59 Quick Ratio3.20 Sales & Book Value Annual Sales£190.60 million Price / Sales5.31 Cash FlowGBX 13.20 per share Price / Cash Flow12.48 Book ValueGBX 91.70 per share Price / Book1.80Miscellaneous Outstanding Shares613,892,000Free FloatN/AMarket Cap£1.01 billion OptionableOptionable BetaN/A Key ExecutivesMr. William Downie (Age 54)CEO & Exec. Director Comp: $538.92kMr. Paul Andrew Fry (Age 54)CFO & Exec. Director Comp: $807kMr. Anthony FitzpatrickExec. VP of OperationsDr. Geraldine VenthoyeChief Scientific Officer & Exec. VP of Product Devel.Elizabeth KnowlesVP of Investor RelationsMr. John Murphy (Age 68)Gen. Counsel & Company Sec. David GinivanVP of Corp. CommunicationsMs. Christina OlsenExec. VP of Corp. Strategy & CommunicationsMs. Joanne Hombal (Age 47)Exec. VP of HR Mr. Roger Heerman (Age 48)Exec. VP of Commercial & Bus. Devel. More ExecutivesKey CompetitorsDechra PharmaceuticalsLON:DPHSpire Healthcare GroupLON:SPICareTechLON:CTHUnipharLON:UPRClinigen GroupLON:CLINView All Competitors VEC Stock - Frequently Asked Questions How have VEC shares performed in 2023? Vectura Group's stock was trading at GBX 164.80 at the beginning of 2023. Since then, VEC stock has increased by 0.0% and is now trading at GBX 164.80. View the best growth stocks for 2023 here. Is Vectura Group a good dividend stock? Vectura Group (LON:VEC) pays an annual dividend of GBX 38 per share and currently has a dividend yield of 23.06%. VEC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 189.05%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for VEC. What other stocks do shareholders of Vectura Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Vectura Group investors own include Hikma Pharmaceuticals (HIK), SEB (SKP), BTG (BTG), iRobot (IRBT), Sinclair Pharma (SPH), Sirius Minerals (SXX), Coats Group (COA), Griffin Mining (GFM), HSBC (HSBA) and Inmarsat (ISAT). What is Vectura Group's stock symbol? Vectura Group trades on the London Stock Exchange (LON) under the ticker symbol "VEC." How do I buy shares of Vectura Group? Shares of VEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Vectura Group's stock price today? One share of VEC stock can currently be purchased for approximately GBX 164.80. How much money does Vectura Group make? Vectura Group (LON:VEC) has a market capitalization of £1.01 billion and generates £190.60 million in revenue each year. How many employees does Vectura Group have? The company employs 9,200 workers across the globe. How can I contact Vectura Group? Vectura Group's mailing address is One Prospect West, CHIPPENHAM, SN14 6FH, United Kingdom. The official website for the company is www.vectura.com. The company can be reached via phone at +44-1249-667700. This page (LON:VEC) was last updated on 5/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vectura Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.